Medicinal Chemistry - Fusion of Traditional and Western Medicine

Volume: 1

First Edition

Indexed in: Book Citation Index, Science Edition, Scopus, EBSCO.

Medicinal Chemistry - Fusion of Traditional and Western Medicine is a textbook intended for students taking courses in the various fields of medicinal chemistry, pharmacy, medical and dental ...
[view complete introduction]

US $

*(Excluding Mailing and Handling)

How New Drugs are Developed: Basic Science, Lead Compound and Proof of Principle

Pp. 87-116 (30)

Robert E. Smith


Drugs are developed in distinct phases. Usually, the drug discovery and development process can be divided into these stages: select a disease, identify a target, find a lead compound, quantify drug-target interactions, determine solubility, pharmacokinetics and toxicity, improve the lead compound, find the best way to deliver the drug to the patient, manufacture the drug, apply to the FDA to do investigational studies, do the clinical studies, apply to the FDA for drug approval, and do post-registration studies. The solubility, pharmacokinetics and toxicity are determined in GLP studies. Similar compounds are tested in the lab and by computer modeling, so structure-activity relationships (SARs) can be developed. Eventually, a new chemical entity (NCE) or investigational new drug (IND) is selected for further evaluation. The optimum method for drug delivery is selected. A manufacturing process is developed and documented according to cGMP. Potential targets include membrane bound receptors (such as GPCRs, tyrosine kinases and intracellular nuclear receptors). Agonists bind to receptors and mimic the action of the endogenous ligand. Antagonists bind to receptors and block the binding and subsequent action of the endogenous ligand. Enzymes, DNA, protein transporters, ion channels and pumps are other potential targets.


New chemical entity, NCE, investigational new drug, IND, quantitative structure-activity relationships, QSAR, agonist, antagonist, cGMP, GLP.


Adjunct Assistant Professor Park University and Consultant Science Advisor United States Food and Drug Administration (FDA) USA